We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$63.7M +$4.91K +52 +0%
NAMA
2
Nikko Asset Management Americas
New York
$48.1M +$15.5M +164,601 +55%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$48.1M +$28.8M +304,472 +192%
RG
4
Redmile Group
California
$40.4M +$2.53M +26,837 +7%
AVM
5
Arch Venture Management
Illinois
$40M +$36.4M +385,505 New
AIM
6
ARK Investment Management
Florida
$39.8M +$406K +4,297 +1%
FP
7
Flagship Pioneering
Massachusetts
$30.5M -$2.51M -26,595 -8%
BlackRock
8
BlackRock
New York
$28.5M +$733K +7,760 +3%
Vanguard Group
9
Vanguard Group
Pennsylvania
$18.6M +$290K +3,068 +2%
SB
10
Samsara BioCapital
California
$17M
DM
11
Deerfield Management
New York
$13.2M
BBA
12
Baker Bros. Advisors
New York
$10.1M
State Street
13
State Street
Massachusetts
$7M +$1.05M +11,093 +20%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$4.93M
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.68M +$52K +551 +1%
6CM
16
683 Capital Management
New York
$4.46M
Northern Trust
17
Northern Trust
Illinois
$4.43M +$899K +9,520 +29%
JP Morgan Chase
18
JP Morgan Chase
New York
$4.37M +$120K +1,275 +3%
Renaissance Technologies
19
Renaissance Technologies
New York
$2.98M -$102K -1,080 -4%
Charles Schwab
20
Charles Schwab
California
$2.07M -$46.1K -488 -2%
CS
21
Candriam SCA
Luxembourg
$1.75M
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.16M +$52.5K +556 +5%
Nuveen
23
Nuveen
North Carolina
$1.12M -$41.2K -436 -4%
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
$801K -$616K -6,527 -46%
Invesco
25
Invesco
Georgia
$801K +$729K +7,721 New